Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis

Liver Cancer

Volumn 5, Issue 3, 2016, Pages 175-189

  Kitai, Satoshi ^a   Kudo, Masatoshi ^a   Nishida, Naoshi ^a   Izumi, Namiki ^b   Sakamoto, Michiie ^c   Matsuyama, Yutaka ^d   Ichida, Takafumi ^e   Nakashima, Osamu ^f   Matsui, Osamu ^g   Ku, Yonson ^h   Kokudo, Norihiro ⁱ   Makuuchi, Masatoshi ^j  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MUSASHINO RED CROSS HOSPITAL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e Shonan East General Hospital   (Japan)

^f KURUME UNIVERSITY HOSPITAL   (Japan)

^g KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^h KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j JAPANESE RED CROSS MEDICAL CENTER   (Japan)

more..

Author keywords

Best supportive care; Child Pugh grade C; Local ablation therapy; Transarterial chemoembolization

Indexed keywords

ABLATION THERAPY; ADULT; ARTICLE; BEST SUPPORTIVE CARE; CANCER PATIENT; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; HEALTH SURVEY; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LOCAL ABLATION THERAPY; LOCAL THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT CARE; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSARTERIAL CHEMOEMBOLIZATION;

EID: 84992171851     PISSN: 22351795     EISSN: 16645553     Source Type: Journal    
DOI: 10.1159/000367765     Document Type: Article

References (28)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529-538.
3. Infante-Rivard C, Esnaola S, Villeneuve JP: Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987;7:660-664.
4. Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T: Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 2004;40:1396-1405.
5. Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M, HCC Expert Panel of Japan Society of Hepatology: Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011;29:339-364.
6. Faber W, Sharafi S, Stockmann M, Denecke T, Sinn B, Puhl G, Bahra M, Malinowski MB, Neuhaus P, Seehofer D: Long-term results of liver resection for hepatocellular carcinoma in noncirrhotic liver. Surgery 2013;153:510-517.
7. Lee Cheah Y, K H Chow P: Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies. Liver Cancer 2012;1:183-189.
8. Chan SC: Liver transplantation for hepatocellular carcinoma. Liver Cancer 2013;2:338-344.
9. Chan SC, Sharr WW, Chan AC, Chok KS, Lo CM: Rescue Living-donor Liver Transplantation for Liver Failure Following Hepatectomy for Hepatocellular Carcinoma. Liver Cancer 2013;2:332-337.
10. Belghiti J, Fuks D: Liver resection and transplantation in hepatocellular carcinoma. Liver Cancer 2012;1:71-82.
11. Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, Mariani L: Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 2011;17(Suppl 2):S44-S57.
12. Lin SM: Local ablation for hepatocellular carcinoma in taiwan. Liver Cancer 2013;2:73-83.
13. Lencioni R: Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-773.
14. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003;37:429-442.
15. Lencioni R: Chemoembolization in patients with hepatocellular carcinoma. Liver Cancer 2012;1:41-50.
16. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J, Barcelona Liver Cancer Group: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
17. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
18. Kudo M: Treatment of advanced hepatocellular carcinoma with emphasis on hepatic arterial infusion chemotherapy and molecular targeted therapy. Liver Cancer 2012;1:62-70.
19. Nouso K, Ito Y, Kuwaki K, Kobayashi Y, Nakamura S, Ohashi Y, Yamamoto K: Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis. Br J Cancer 2008;98:1161-1165.
20. Kudo M, Osaki Y, Matsunaga T, Kasugai H, Oka H, Seki T: Hepatocellular carcinoma in Child-Pugh C cirrhosis: prognostic factors and survival benefit of nontransplant treatments. Dig Dis 2013;31:490-498.
21. Bruix J, Sherman M Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
22. Izumi N: Diagnostic and treatment algorithm of the Japanese society of hepatology: a consensus-based practice guideline. Oncology 2010;78(Suppl 1):78-86.
23. European Association For The Study Of The Liver European Organisation For Research And Treatment Of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-943.
24. Kudo M: Real practice of hepatocellular carcinoma in Japan: conclusions of the Japan Society of Hepatology 2009 Kobe Congress. Oncology 2010;78(Suppl 1):180-188.
25. Minami Y, Kitai S, Kudo M: Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation. Eur J Radiol 2012;81:e277-e280.
26. Takayasu K: Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective. Oncology 2011;81(Suppl 1):105-110.
27. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M, Yamaoka Y, Liver Cancer Study Group of Japan: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006;131:461-469.
28. Tamura S, Sugawara Y, Kokudo N: Living donor liver transplantation for hepatocellular carcinoma: the Japanese experience. Oncology 2011;81(Suppl 1):111-115.